HEPATIC IMPAIRMENT MEASURED BY QUANTITATIVE TESTS OF LIVER FUNCTION (QLFTS) PREDICTS CLINICAL OUTCOME IN PATIENTS WITH ADVANCED FIBROSIS: RESULTS FROM THE HEPATITIS C ANTIVIRAL LONG-TERM TREATMENT AGAINST CIRRHOSIS (HALT-C) TRIAL

被引：0
|
作者：
Everson, Gregory T. [1 ]
Hoefs, John C. [2 ]
Shiffman, Mitchell L. [3 ]
Morgan, Timothy R. [2 ]
Sterling, Richard K. [3 ]
Curto, Teresa M. [5 ]
Wagner, David [4 ]
Wright, Elizabeth C. [6 ]
Everhart, James E. [6 ]
机构：
[1] Univ Colorado, Transplant Ctr & Hepatol, Aurora, CO USA
[2] Univ Calif Irvine, Div Gastroenterol & Hepatol, Irvine, CA USA
[3] VCU, Sect Hepatol, Richmond, VA USA
[4] Metab Solut, Nashua, NH USA
[5] New England Res Inst, Watertown, MA 02172 USA
[6] NIDDK, Bethesda, MD USA
来源：
HEPATOLOGY | 2009年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1627
引用
收藏
页码：1057A / 1058A
页数：2
相关论文
共 50 条
  • [41] Long-term liver stiffness assessment in hepatitis C virus patients undergoing antiviral therapy: Results from a 5-year cohort study
    Facciorusso, Antonio
    Del Prete, Valentina
    Turco, Antonio
    Buccino, Rosario Vincenzo
    Nacchiero, Maurizio Cosimo
    Muscatiello, Nicola
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (04) : 942 - 949
  • [42] Does successful viral eradication translate into beneficial long-term clinical outcome of patients with advanced liver disease due to hepatitis C after DAA therapy?
    Kozbial, Karin
    Moser, Stephan
    Schwarzer, Remy
    Al Zoairy, Ramona
    Stauber, Rudolf E.
    Laferl, Hermann
    Maieron, Andreas
    Zoller, Heinz M.
    Beinhardt, Sandra
    Staettermayer, Albert
    Stern, Rafael
    Steindl-Munda, Petra E.
    Strasser, Michael P.
    Peck-Radosavljevic, Markus
    Graziadei, Ivo
    Trauner, Michael H.
    Hofer, Harald
    Ferenci, Peter
    HEPATOLOGY, 2016, 64 : 447A - 447A
  • [43] Long-term fibrosis improvement after sustained virologic response in patients with chronic hepatitis C and advanced fibrosis or cirrhosis - pre-treatment cirrhosis, older age and high body mass index increases the risk for persisting fibrosis
    Hedenstierna, M.
    Nangarhari, A.
    Weiland, O.
    Aleman, S.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S493 - S494
  • [44] Long-term improvement of liver function parameters after IFN-free therapy of advanced HCV-associated liver cirrhosis - Results from the German Hepatitis C-Registry (DHC-R)
    Deterding, Katja
    Mauss, Stefan
    Pathil, Anita
    Buggisch, Peter
    Schott, Eckart
    Cornberg, Markus
    Zimmermann, Tim
    Simon, Karl-Georg
    Klinker, Hartwig H.
    Guenther, Rainer
    Heike, Pfeiffer-Vornkahl
    Hueppe, Dietrich
    Sarrazin, Christoph
    Zeuzem, Stefan
    Manns, Michael P.
    Wedemeyer, Heiner
    Berg, Thomas
    HEPATOLOGY, 2017, 66 : 847A - 848A
  • [45] SCREENING AND SURVEILLANCE OF ESOPHAGEAL VARICES IN PATIENTS WITH HEPATITIS C VIRUS-POSITIVE LIVER CIRRHOSIS AND A SUSTAINED VIROLOGICAL RESPONSE TO DIRECT ACTING ANTIVIRAL AGENTS: RESULTS OF A LONG-TERM PROSPECTIVE COHORT STUDY
    Ciancio, Alessia
    Ribaldone, Davide Giuseppe
    Salamone, Rossella
    Sacco, Marco
    Saracco, Giorgio Maria
    HEPATOLOGY, 2021, 74 : 1260A - 1260A
  • [46] The Effects of Long Term PEG-Interferon Therapy On the Development of Esophageal Varices and Variceal Bleeding Jn Patients with Hepatitis C and Advanced Fibrosis: Final Results from the Copilot Trial
    Cardenas, Andres
    Pritchett, Sean
    Brown, Robert S.
    Levine, Robert A.
    Curry, Michael P.
    Afdhal, Nezam H.
    GASTROENTEROLOGY, 2009, 136 (05) : A795 - A795
  • [47] Long-term follow-up after IFN-free therapy of advanced HCV-associated liver cirrhosis: continued improvement of liver function parameters - Results from the German Hepatitis C-Registry (DHC-R)
    Deterding, K.
    Mauss, S.
    Pathil, A.
    Buggisch, P.
    Schott, E.
    Cornberg, M.
    Zimmermann, T.
    Simon, K. -G.
    Klinker, H.
    Gunther, R.
    Pfeiffer-Vornkahl, H.
    Hueppe, D.
    Sarrazin, C.
    Zeuzem, S.
    Manns, M. P.
    Wedemeyer, H.
    Berg, T.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S55 - S55
  • [48] SUSTAINED VIROLOGIC RESPONSE AND POSTTREATMENT LIVER FUNCTION ARE ASSOCIATED WITH 5-YEAR SURVIVAL AFTER DIRECT-ACTING ANTIVIRAL TREATMENT IN DECOMPENSATED CIRRHOTIC PATIENTS WITH HEPATITIS C VIRUS: A LONG-TERM FOLLOW UP STUDY OF JAPANESE CLINICAL TRIAL COHORT
    Tahata, Yuki
    Hikita, Hayato
    Takaki, Akinobu
    Kurosaki, Masayuki
    Matsuura, Kentaro
    Yatsuhashi, Hiroshi
    Kuroda, Hidekatsu
    Ueno, Yoshiyuki
    Kodama, Takahiro
    Sakamori, Ryotaro
    Tatsumi, Tomohide
    Takehara, Tetsuo
    HEPATOLOGY, 2024, 80 : S344 - S345
  • [49] Evaluation of the Long-Term Health Outcomes of Ledipasivir/Sofosbuvir (LDV/SOF) and Sofosbuvir-based Regimens for Patients With Chronic Hepatitis C (CHC) And Liver Cirrhosis Across Genotypes 1 to 4 (GT 1-4): Results from a Decision-Analytic Markov Model
    Gordon, Stuart C.
    Ahmed, Aijaz
    Saab, Sammy
    Younossi, Zobair
    HEPATOLOGY, 2014, 60 : 1040A - 1041A
  • [50] Continued Low Rates of Hepatitis C Virus (HCV) Recurrence in HCV/HIV- and HCV-Infected Participants Who Achieved Sustained Virologic Response After Direct-Acting Antiviral Treatment: Final Results From the AIDS Clinical Trials Group A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS)
    Wyles, David L.
    Kang, Minhee
    Matining, Roy M.
    Murphy, Robert L.
    Peters, Marion G.
    OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (12):
12345